Haffty BG - Search Results

1

Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.

Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG. Khan AJ, et al. Among authors: haffty bg. Clin Cancer Res. 2002 Feb;8(2):540-8. Clin Cancer Res. 2002. PMID: 11839675

2

Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.

Rodrigues NA, Dillon D, Carter D, Parisot N, Haffty BG. Rodrigues NA, et al. Among authors: haffty bg. Cancer. 2003 Mar 15;97(6):1393-403. doi: 10.1002/cncr.11204. Cancer. 2003. PMID: 12627502 Free article.

3

A comparison of five immunohistochemical biomarkers and HER-2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early-onset breast carcinoma.

Choi DH, Shin DB, Lee MH, Lee DW, Dhandapani D, Carter D, King BL, Haffty BG. Choi DH, et al. Among authors: haffty bg. Cancer. 2003 Oct 15;98(8):1587-95. doi: 10.1002/cncr.11703. Cancer. 2003. PMID: 14534873 Free article.

4

Molecular markers for prognosis after isolated postmastectomy chest wall recurrence.

Haffty BG, Hauser A, Choi DH, Parisot N, Rimm D, King B, Carter D. Haffty BG, et al. Cancer. 2004 Jan 15;100(2):252-63. doi: 10.1002/cncr.11915. Cancer. 2004. PMID: 14716758 Free article.

5

Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.

Smith BD, Smith GL, Haffty BG. Smith BD, et al. Among authors: haffty bg. J Clin Oncol. 2005 Mar 1;23(7):1409-19. doi: 10.1200/JCO.2005.05.100. J Clin Oncol. 2005. PMID: 15735117

6

Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.

Smith BD, Haffty BG. Smith BD, et al. Among authors: haffty bg. Radiat Oncol Investig. 1999;7(3):125-44. doi: 10.1002/(SICI)1520-6823(1999)7:3<125::AID-ROI1>3.0.CO;2-W. Radiat Oncol Investig. 1999. PMID: 10406054 Review.

7

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma.

Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG. Smith BD, et al. Among authors: haffty bg. J Clin Oncol. 2000 May;18(10):2046-52. doi: 10.1200/JCO.2000.18.10.2046. J Clin Oncol. 2000. PMID: 10811669

8

Molecular markers in head and neck squamous cell carcinoma: their biological function and prognostic significance.

Smith BD, Haffty BG, Sasaki CT. Smith BD, et al. Among authors: haffty bg. Ann Otol Rhinol Laryngol. 2001 Mar;110(3):221-8. doi: 10.1177/000348940111000304. Ann Otol Rhinol Laryngol. 2001. PMID: 11269765 Review.

9

Adenoid cystic carcinoma: a retrospective clinical review.

Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, Haffty BG. Khan AJ, et al. Among authors: haffty bg. Int J Cancer. 2001 Jun 20;96(3):149-58. doi: 10.1002/ijc.1013. Int J Cancer. 2001. PMID: 11410883 Review.

10

Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.

Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT, Haffty BG. Smith BD, et al. Among authors: haffty bg. Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):780-5. Arch Otolaryngol Head Neck Surg. 2001. PMID: 11448349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

507 results

Search Page

Filters